🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is aimed to the test efficacy and safety of neoantigen-primed den...
Status
Recruiting
Location
Qiu Li
Start Date
2019-06-01
Trial ID
NCT04147078
Treatments Being Tested
The purpose of this study is: 1. To compare priming with Granulocyte-Macro...
Status
Completed
Location
Multiple Locations
Start Date
1999-03
Trial ID
NCT00880243
Treatments Being Tested
The investigators will examine mental/cognitive as well as cognitive functi...
Status
Completed
Location
Pain and Rehabilitation Centre
Start Date
2018-01-01
Trial ID
NCT05452915
Treatments Being Tested
Objectives: * To assess the safety of three priming immunisations by nasal...
Status
Completed
Location
Surrey Clinical Research Centre University of Surrey
Start Date
2012-01
Trial ID
NCT01509144
The goal of this clinical trial is to explore the effects of intermittent t...
Status
Recruiting
Location
The Hong Kong Polytechnic University, Department of Rehabilitation Sciences
Start Date
2025-01-05
Trial ID
NCT07497334
Treatments Being Tested
The purpose of this study is to test the safety of a course of injections c...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-11
Trial ID
NCT01984892
Treatments Being Tested
Children and adults with recurrent or progressive malignant brain tumors ha...
Status
Completed
Location
University of California, San Francisco
Start Date
2022-04-22
Trial ID
NCT05169944
Treatments Being Tested
The primary purpose of this study is to determine whether PCI added to OMT ...
Status
Unknown
Location
Myeong-Ki, Hong
Start Date
2010-08
Trial ID
NCT01508663
Infants in malaria-endemic regions of Africa are an important target for va...
Status
Completed
Location
Medical Research Council Laboratories
Start Date
2011-10
Trial ID
NCT01450293
Treatments Being Tested
This is a first in human testing of novel HIV-1 protein nanoparticles vacci...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2024-01-30
Trial ID
NCT06541093